Treatment of heart failure with preserved ejection fraction: have we been pursuing the wrong paradigm?
about
Heart failure with preserved ejection fraction: emerging drug strategiesLong-term survival for patients with acute decompensated heart failure according to ejection fraction findingsEffect of fluid and dietary sodium restriction in the management of patients with heart failure and preserved ejection fraction: study protocol for a randomized controlled trialThe Nitrate-Nitrite-NO Pathway and Its Implications for Heart Failure and Preserved Ejection FractionPhysical activity ameliorates cardiovascular health in elderly subjects: the functional role of the β adrenergic system.Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction.Heart failure in hypertension: prevention and treatment.Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target.Current perspectives on systemic hypertension in heart failure with preserved ejection fraction.Evaluation of efficacy of metoprolol in patients having heart failure with preserved ejection fraction: A randomized, double-blind, placebo-controlled pilot trial.[Diastolic heart failure: heart failure with preserved ejection fraction].Autonomic regulation therapy to enhance myocardial function in heart failure patients: the ANTHEM-HFpEF study.Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview.Relationship of Transmural Variations in Myofiber Contractility to Left Ventricular Ejection Fraction: Implications for Modeling Heart Failure Phenotype With Preserved Ejection Fraction
P2860
Q24595118-2CED0E56-AEB6-4EC9-A009-20CD50A52AA2Q34173702-95820B89-8FA3-40E3-BD0A-76EB655A4366Q34174520-79FC57A8-D4D2-4A92-A776-A0EF75F37516Q36584873-D5E7F33F-B0D5-41D3-9BF3-5E6D68F99498Q37086960-5F29C2E0-6E11-4088-9CDE-5278DB609A26Q37203236-F73B24CD-95DE-4996-9867-DF0C0D3BD6DEQ38022713-7FE6259F-3C66-46A5-A843-2AF8E17E098FQ38134311-D609EACA-0010-4C6F-A094-71E8DD9CAB6CQ38261197-84F2A20D-59D0-4F63-8F27-562BCF8215ECQ41250771-EE163DA9-3CBF-4B23-B3FD-6D6AFA99E1AAQ45393684-4FF06E7F-6320-4D2C-999D-6F70A3C88AB1Q47667565-B95C6A17-D383-4C1B-8A17-89F8A62442EAQ55610979-41315BDE-8D2C-49FF-9724-CA4E9CDCDBC6Q58705696-A0502C14-78CF-4837-A785-90F1968E368A
P2860
Treatment of heart failure with preserved ejection fraction: have we been pursuing the wrong paradigm?
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Treatment of heart failure wit ...... n pursuing the wrong paradigm?
@ast
Treatment of heart failure wit ...... n pursuing the wrong paradigm?
@en
type
label
Treatment of heart failure wit ...... n pursuing the wrong paradigm?
@ast
Treatment of heart failure wit ...... n pursuing the wrong paradigm?
@en
prefLabel
Treatment of heart failure wit ...... n pursuing the wrong paradigm?
@ast
Treatment of heart failure wit ...... n pursuing the wrong paradigm?
@en
P2093
P2860
P356
P1476
Treatment of heart failure wit ...... n pursuing the wrong paradigm?
@en
P2093
Gerard O Oghlakian
Ilke Sipahi
James C Fang
P2860
P304
P356
10.4065/MCP.2010.0841
P407
P577
2011-05-16T00:00:00Z